Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

Development of more efficacious TC-99M organ imaging agents for use in nuclear medicine by analytical characterization of radiopharmaceutical mixtures. Progress report, May 1, 1983-April 1, 1984

Technical Report ·
OSTI ID:5234471
It has been demonstrated that formulation variables (pH, TcO/sub 4//sup -/ concentration, and ligand-to-metal ratio) influence the chromatographic distribution of the components of a Tc-hydroxyethylidene diphosphonate (HEDP) mixture prepared by the NaBH/sub 4/ reduction of TcO/sub 4//sup -/ in the presence of HEDP. The use of alternate reductants for TcO/sub 4//sup -/ (i.e., SnCl/sub 2/, and electrode) not only alters the relative proportion of the Tc-HEDP components formed, but produces new complexes not previously seen (based on chromatographic retention time data). Thus, a systematic evaluation has been undertaken of the SnCl/sub 2/ and electrochemical reduction preparations that is similar to that conducted for Tc(NaBH/sub 4/)-HEDP mixtures. High performance liquid chromatography with electrochemical detection has been utilized to separate components of a Tc(NaBH4)-methylene diphosphonate mixture. All Tc components of the mixture are reducible at a mercury electrode and hydrodynamic voltammetric data is being generated. Stripping chronocoulometry has been developed as a novel variation of anodic stripping voltammetry in order to increase precision in the analytical determination of TcO/sub 4//sup -/ in aqueous solution. Pilot studies to evaluate the operating parameters of /sup 99/Mo//sup 99m/Tc/ generators and to investigate two new diphosphonate ligands in the preparation of technetium skeletal imaging radiopharmaceutical analogs have been initiated.
Research Organization:
Cincinnati Univ., OH (USA). Dept. of Chemistry
DOE Contract Number:
AC02-80EV10380
OSTI ID:
5234471
Report Number(s):
DOE/EV/10380-4; ON: DE84007336
Country of Publication:
United States
Language:
English